| |
|
|
| Name: |
Avidity Partners Management LP |
| City: |
Dallas |
| State: |
TX |
| Zip: |
75201 |
| |
|
|
| Achive
data |
| View
Filing Period: |
|
|
|
|
|
|
 |
Download |
|
|
| |
| |
|
Free Registration Required For Full Results
|
|
|
| Holdings
Found :
25 |
|
View All Holdings |
Currently
Viewing:
Increased Positions |
|
|
Page 1 of 1 |
Menu
 |
Ticker |
Company Name |
Position
Rank |
New/Closed
Postion |
Last
Close |
Value |
Shares Held |
% of
Portfolio |
Value
Change |
Change In
Shares Held |
% of Company |
Industry |
|
ARVN |
Arvinas Holding Company, Llc |
1 |
- |
$34.33 |
$122,867,000 |
2,985,117 |
4.7% |
71,509,000 |
370,157 |
5.61 |
N/A |
|
|
ACHC |
Acadia Healthcare Company Inc |
4 |
- |
$73.18 |
$89,944,000 |
1,156,692 |
3.44% |
39,672,000 |
441,692 |
1.167 |
N/A |
|
|
NBIX |
Neurocrine Biosciences Inc |
5 |
- |
$143.19 |
$86,698,000 |
658,000 |
3.32% |
13,337,000 |
5,900 |
0.704 |
Biotechnology |
|
|
SNDX |
Syndax Pharmaceuticals Inc |
6 |
- |
$23.18 |
$85,360,000 |
3,950,000 |
3.26% |
44,399,000 |
1,129,000 |
5.145 |
N/A |
|
|
NTRA |
Natera, Inc. |
7 |
- |
$97.15 |
$69,530,000 |
1,110,000 |
2.66% |
29,749,000 |
211,000 |
1.018 |
N/A |
|
|
DHR |
Danaher Corp |
8 |
- |
$248.76 |
$67,089,000 |
290,000 |
2.57% |
23,275,000 |
113,400 |
0.041 |
General Building Mate... |
|
|
FUSN |
Fusion Pharmaceuticals Inc. |
11 |
- |
$21.40 |
$62,468,000 |
6,500,328 |
2.39% |
47,435,000 |
718,478 |
13.583 |
N/A |
|
|
REGN |
Regeneron Pharmaceuticals Inc |
13 |
- |
$969.97 |
$59,724,000 |
68,000 |
2.28% |
11,992,000 |
10,000 |
0.065 |
Biotechnology |
|
|
RCKT |
Rocket Pharmaceuticals |
19 |
- |
$23.36 |
$51,522,000 |
1,719,103 |
1.97% |
18,996,000 |
131,674 |
2.184 |
N/A |
|
|
LLY |
Eli Lilly & Co |
21 |
- |
$777.77 |
$49,548,000 |
85,000 |
1.89% |
9,263,000 |
10,000 |
0.009 |
Drug Manufacturers - ... |
|
|
ABBV |
Abbvie Inc. |
26 |
- |
$162.55 |
$44,074,000 |
284,405 |
1.69% |
44,074,000 |
284,405 |
0.016 |
Drug Manufacturers - ... |
|
|
GPCR |
Structure Therapeutics Inc. |
27 |
- |
$39.33 |
$44,021,000 |
1,080,000 |
1.68% |
18,811,000 |
580,000 |
2.822 |
N/A |
|
|
RARE |
Ultragenyx Pharmaceutical Inc |
31 |
- |
$41.96 |
$40,384,000 |
844,500 |
1.54% |
20,990,000 |
300,500 |
1.239 |
Restaurants |
|
|
XENE |
Xenon Pharmaceuticals Inc. |
33 |
- |
$0.00 |
$37,585,000 |
815,993 |
1.44% |
26,606,000 |
494,593 |
1.305 |
N/A |
|
|
AXSM |
Axsome Therapeutics, Inc. |
35 |
- |
$76.94 |
$36,564,000 |
459,400 |
1.4% |
15,821,000 |
162,600 |
1.23 |
N/A |
|
|
CRBU |
Caribou Biosciences, Inc. |
36 |
- |
$3.73 |
$36,444,000 |
6,360,212 |
1.39% |
7,524,000 |
310,000 |
10.606 |
N/A |
|
|
NMRA |
Neumora Therapeutics, Inc. |
38 |
- |
$9.81 |
$33,940,000 |
1,990,632 |
1.3% |
8,542,000 |
190,632 |
1.304 |
N/A |
|
|
ANTX |
An2 Therapeutics Ord Shs |
44 |
- |
$2.55 |
$23,359,000 |
1,140,000 |
0.89% |
5,841,000 |
50,600 |
5.873 |
N/A |
|
|
ACIU |
AC Immune SA |
45 |
- |
$2.38 |
$22,345,000 |
4,469,080 |
0.85% |
13,881,000 |
1,499,280 |
6.23 |
N/A |
|
|
PHAT |
Phathom Pharmaceuticals, Inc. |
49 |
- |
$0.00 |
$15,718,000 |
1,721,580 |
0.6% |
-1,053,000 |
104,280 |
5.045 |
N/A |
|
|
NTLA |
Intellia Therapeutics, Inc. |
53 |
- |
$23.88 |
$13,642,000 |
447,434 |
0.52% |
1,655,000 |
68,334 |
0.5 |
N/A |
|
|
SYRS |
Syros Pharmaceuticals, Inc. |
54 |
- |
$5.15 |
$13,037,000 |
1,673,538 |
0.5% |
6,791,000 |
92,396 |
2.978 |
N/A |
|
|
COLL |
Collegium Pharmaceutical, Inc |
58 |
- |
$37.30 |
$11,123,000 |
361,363 |
0.43% |
3,296,000 |
11,163 |
0.871 |
N/A |
|
|
IPSC |
Century Therapeutics, Inc. |
65 |
- |
$0.00 |
$4,499,000 |
1,355,000 |
0.17% |
2,302,000 |
256,500 |
2.472 |
N/A |
|
|
SCYX |
Scynexis Inc |
66 |
- |
$1.85 |
$3,231,000 |
1,448,728 |
0.12% |
223,000 |
129,284 |
6.049 |
N/A |
|
